15th May, “Efavirenz Tablets”, another striking anti-AIDS medicine of Biochem passed the technical examination of National Medical Products Administration and got the permission to enter the market. It was Biochem’s second drug permitted by then, following its lamivudine, an anti-AIDS drug.